Skip to the page

Data / Form D filings / RxCap, Inc.

RxCap, Inc.: Form D filings

RxCap, Inc., a technology company in Lynnfield, MA, filed 2 Form D notices with the SEC in 2024. The latest, on May 8, 2024, reports $19.7 million sold of a $21.2 million offering to 22 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
14 RUSSET LANE, Lynnfield, MA, 01940
Phone
1-617-880-9361
Industry
Other Technology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2019
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2021904

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
May 8, 2024Amendment$21,156,047$19,656,048$1,499,99922Apr 25, 2024sec.gov
May 6, 2024New notice$21,156,047$19,656,048$1,499,99922Apr 25, 2024sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
John ReaDirector
Toby HabaDirector
Will ShrankDirector
Mike FurlottiDirector
Sreeram RamakrishnanExecutive Officer, Director

Other technology companies in Massachusetts that filed recently

Every Form D from the week of May 6, 2024 · All recent filings in Massachusetts · All recent Other Technology filings

Read from SEC EDGAR. Amount sold is what RxCap, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.